ELEDON PHARMACEUTICALS INC (ELDN)
US28617K1016 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -40.33M | -87.97M | -34.51M | -22.81M | -16.01M | |||
| Depreciation Amortization | N/A | N/A | 0.00 | 10.00K | 10.00K | |||
| Income Taxes - Deferred | N/A | 0.00 | -2.35M | -400.00K | N/A | |||
| Change In Working Capital | -4.92M | 2.37M | -150.00K | -180.00K | -1.20M | |||
| Other non cash items | 5.72M | 57.17M | 8.10M | 8.18M | 3.35M | |||
| OPERATING CASH FLOW | -39.53M | -28.42M | -28.91M | -15.21M | -13.86M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| Other Investing Activity | -45.29M | N/A | 0.00 | 11.04M | N/A | |||
| INVESTING CASH FLOW | -45.29M | N/A | 0.00 | 11.04M | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 33.02M | 0.00 | 0.00 | 109.61M | 9.68M | |||
| Other Financing Activity | N/A | 0.00 | -450.00K | -30.00K | N/A | |||
| FINANCING CASH FLOW | 33.02M | 0.00 | -450.00K | 109.58M | 9.68M | |||
| CHANGE IN CASH | -51.80M | -28.42M | -29.36M | 105.41M | -4.18M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -39.53M | -28.42M | -28.91M | -15.21M | -13.86M | |||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| FREE CASH FLOW | -39.53M | -28.42M | -28.91M | -15.21M | -13.86M | |||
All data in USD